Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
92.20
+1.65 (1.82%)
At close: Apr 17, 2026, 4:00 PM EDT
92.00
-0.20 (-0.22%)
After-hours: Apr 17, 2026, 6:33 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $6.81 billion as of April 17, 2026. Its market cap has increased by 229.17% in one year.
Market Cap
6.81B
Enterprise Value
5.94B
1-Year Change
229.17%
Ranking
Category
Stock Price
$92.20
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $6.81B, an increase of 741.74%. That is a compound annual growth rate of 116.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 6.69B | 31.27% |
| Dec 31, 2025 | 5.09B | 97.62% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 7.49B |
| Kymera Therapeutics | 7.03B |
| Arcellx | 6.75B |
| Protagonist Therapeutics | 6.62B |
| Belite Bio | 6.22B |
| Centessa Pharmaceuticals | 6.11B |
| Terns Pharmaceuticals | 6.08B |
| Celcuity | 6.05B |